Data / Drug companies / Diethylpropion hydrochloride
Diethylpropion hydrochloride: 12 companies and 22 products in the FDA NDC directory
Diethylpropion hydrochloride is listed in the FDA National Drug Code Directory by 12 companies, with 22 products in commercial distribution. 22 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release, and the newest product started marketing on September 19, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 22
- Generic (ANDA) products
- 22 (100.0%)
- Application numbers
- 3
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list diethylpropion hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| A-S Medication Solutions | 2 | tablet, extended release; tablet | Generic drugs (ANDA) | October 24, 2011 |
| Calvin Scott & Co., Inc. | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| Chartwell RX, LLC | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| Lannett Company, Inc. | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| Proficient Rx LP | 2 | tablet, extended release; tablet | Generic drugs (ANDA) | October 24, 2011 |
| KVK-Tech, Inc. | 1 | tablet | Generic drugs (ANDA) | December 27, 2010 |
| Martek Pharmacal Co. | 1 | tablet | Generic drugs (ANDA) | March 5, 2024 |
| Omnivium Pharmaceuticals LLC. | 1 | tablet, extended release | Generic drugs (ANDA) | September 19, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | July 18, 2011 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 13 | 59.1% |
| Tablet, extended release | 9 | 40.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sympathomimetic Amine Anorectic | 22 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.